Уважаемые пользователи!
Мы рады представить вам новую версию сайта с улучшенным интерфейсом и новыми возможностями.
Приглашаем вас ознакомиться и поделиться обратной связью. Спасибо, что вы с нами!
Попробовать!
RUEN

Statin Use Associated With Musculoskeletal Adverse Events

10.06.20132543
Statin use is associated with an increased risk of musculoskeletal conditions, arthropathies, injuries and pain, according to a new retrospective analysis published June 3 in JAMA Internal Medicine.

Lack of Reduction of Left Ventricular Mass in Treated Hypertension: The Strong Heart Study

07.06.20132298
Hypertensive left ventricular mass (LVM) is expected to decrease during antihypertensive therapy, based on results of clinical trials.

Good Prognosis for Pericarditis With and Without Myocardial Involvement: Results from a Multicenter Prospective Cohort Study

06.06.20132023
The natural history of myopericarditis/perimyocarditis is poorly known and recently published data have presented contrasting data on their outcomes.

The use of cholinesterase inhibitors and the risk of myocardial infarction and death: a nationwide cohort study in subjects with Alzheimer's disease

05.06.20132326
Cholinesterase inhibitors (ChEIs) are used for symptomatic treatment of Alzheimer's disease. These drugs have vagotonic and anti-inflammatory properties that could be of interest also with respect to cardiovascular disease.

Gestational Diabetes May Signal Future Risk

04.06.20132171
Women with gestational diabetes who have a cluster of symptoms typical of metabolic syndrome are more likely to go on to develop diabetes over 10 years, researchers found.

Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial

03.06.20132092
Mineralocorticoid receptor antagonists (MRAs) improve outcomes in patients with heart failure and reduced left ventricular ejection fraction (HFrEF), but their use is limited by hyperkalaemia and/or worsening renal function (WRF).

Risk of incident diabetes among patients treated with statins: population based study

31.05.20132356
To examine the risk of new onset diabetes among patients treated with different HMG-CoA reductase inhibitors (statins).
123...979899100101...153154155
Enter the Society
Subscribe to Newsletter
Данный сайт и вся информация на нём предназначена для медицинских работников. Продолжая просмотр, вы соглашаетесь и подтверждаете, что являетесь медицинским работником.